Peter Evan Harwin
Director, 10% owner, Crescent Biopharma, Inc.; Director, Zenas BioPharma, Inc.
Bought, 12 months
$18.2M
Sold, 12 months
$0.0M
Companies
2
Latest trade
Dec 4, 2025
Companies
Crescent Biopharma, Inc.Director, 10% owner +$18.2M Zenas BioPharma, Inc.Director +$6.0MTrades
Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.

